​

Madrigal Pharmaceuticals Ownership | Who Owns Madrigal Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Madrigal Pharmaceuticals Ownership Summary

Madrigal Pharmaceuticals is owned by 106.11% institutional investors, 7.70% insiders. Janus henderson group is the largest institutional shareholder, holding 10.16% of MDGL shares. Janus Concentrated Growth CF is the top mutual fund, with 2.72% of its assets in Madrigal Pharmaceuticals shares.

MDGL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMadrigal Pharmaceuticals106.11%7.70%-13.81%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group2.21M10.16%$681.37M
Paulson2.09M9.41%$632.37M
Rtw investments, lp1.99M8.98%$603.37M
Baker bros. advisors lp1.98M8.90%$598.02M
Avoro capital advisors1.88M8.44%$567.45M
Vanguard group1.71M7.85%$526.46M
Blackrock1.43M7.14%$399.86M
Blackrock funding, inc. /de1.44M6.48%$435.42M
Fmr867.85K3.99%$267.79M
State street744.71K3.72%$208.64M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Paulson2.09M31.44%$632.37M
Tao capital management lp112.78K25.03%$34.13M
University of wisconsin foundation48.38K16.38%$14.64M
Avoro capital advisors1.88M9.94%$567.45M
Rtw investments, lp1.99M8.59%$603.37M
Baker bros. advisors lp1.98M5.80%$598.02M
Nan fung group11.87K5.66%$3.59M
Bioimpact capital100.42K5.27%$30.39M
Stempoint capital lp52.69K5.12%$15.95M
Affinity asset advisors80.00K3.31%$24.21M

Top Buyers

HolderShares% AssetsChange
Blackrock1.43M0.01%216.86K
Adage capital partners gp376.16K0.19%184.55K
Woodline partners lp309.12K0.64%162.03K
Ubs group325.27K0.02%144.64K
State street744.71K0.01%119.78K

Top Sellers

HolderShares% AssetsChange
Holocene advisors, lp---390.55K
Janus henderson group2.21M0.35%-269.77K
Ra capital management---204.50K
Bain capital life sciences investors---197.00K
Tcg crossover management---149.28K

New Positions

HolderShares% AssetsChangeValue
Norges bank115.09K0.00%115.09K$35.51M
Logos global management lp50.00K1.67%50.00K$15.13M
Avidity partners management lp19.00K1.15%19.00K$5.75M
Kornitzer capital management inc /ks14.76K0.09%14.76K$4.55M
Twin tree management, lp9.74K0.01%9.74K$3.00M

Sold Out

HolderChange
Atlas capital advisors-1.00
Fifth third bancorp-1.00
True wealth design-1.00
Nelson, van denburg & campbell wealth management group-2.00
Physician wealth advisors-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025325-4.69%23,563,8530.96%1060.95%144-20.00%11118.09%
Mar 31, 20253416.90%23,616,0522.83%1060.96%1784.09%9626.32%
Dec 31, 20243005.63%19,963,834-11.66%910.85%15720.77%75-14.77%
Sep 30, 2024281-1.75%22,596,992-0.11%1030.81%128-20.99%8731.82%
Jun 30, 2024286-7.44%22,622,1418.92%1131.05%162-1.22%66-20.48%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Janus Concentrated Growth CF604.92K2.72%-27.38K
Janus Henderson Forty S604.92K2.72%-
Vanguard Total Stock Mkt Idx Inv598.65K2.69%-12.61K
Vanguard US Total Market Shares ETF578.31K2.62%388.00
Vanguard Small Cap Index458.31K2.06%-2.70K
iShares Russell 2000 ETF397.53K1.79%-7.56K
Janus Henderson Opportunistic Alpha MA319.65K1.47%319.62K
Janus Henderson US Opportunistic Alpha304.98K1.37%-52.93K
Janus Henderson Contrarian D304.98K1.37%-
SPDR® S&P Biotech ETF297.88K1.34%7.37K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 21, 2025Sibold William John President and CEOSell$453.53K
Aug 21, 2025Sibold William John President and CEOSell$2.59M
Aug 20, 2025BAKER BROS. ADVISORS LP-Buy$977.06K
Aug 20, 2025BAKER BROS. ADVISORS LP-Buy$3.67M
Aug 20, 2025BAKER BROS. ADVISORS LP-Buy$142.37K

Insider Transactions Trends

DateBuySell
2025 Q35477
2025 Q2--
2025 Q1-56
2024 Q4-10
2024 Q3-1

MDGL Ownership FAQ

Who Owns Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals shareholders are primarily institutional investors at 106.11%, followed by 7.70% insiders and -13.81% retail investors. The average institutional ownership in Madrigal Pharmaceuticals's industry, Biotech Stocks , is 304.14%, which Madrigal Pharmaceuticals falls below.

Who owns the most shares of Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals’s largest shareholders are Janus henderson group (2.21M shares, 10.16%), Paulson (2.09M shares, 9.41%), and Rtw investments, lp (1.99M shares, 8.98%). Together, they hold 28.54% of Madrigal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Madrigal Pharmaceuticals?

Yes, BlackRock owns 7.14% of Madrigal Pharmaceuticals, totaling 1.43M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 399.86M$. In the last quarter, BlackRock increased its holdings by 216.86K shares, a 17.92% change.

Who is Madrigal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Paulson is Madrigal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 31.44% of its assets in 2.09M Madrigal Pharmaceuticals shares, valued at 632.37M$.

Who is the top mutual fund holder of Madrigal Pharmaceuticals shares?

Janus Concentrated Growth CF is the top mutual fund holder of Madrigal Pharmaceuticals shares, with 2.72% of its total shares outstanding invested in 604.92K Madrigal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools